designer491 / iStockphoto.com
17 October 2017Americas
Allergan deal with tribe could kill off IPR: Bryson
A US judge has said Allergan’s controversial patent licensing deal with a Native American tribe could spell the end for the inter partes review (IPR).
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
30 November 2017 A group of Miami police officers has filed a competition lawsuit on behalf of “potentially millions” of consumers over Allergan’s $13.75 million patent deal with the Saint Regis Mohawk Tribe.
Americas
19 January 2018 Generics company Mylan Pharmaceuticals has resisted Allergan’s attempt to withdraw itself from a series of inter partes reviews (IPRs) relating to patents covering dry-eye medication Restasis (cyclosporine ophthalmic emulsion).
Americas
21 August 2018 Allergan and the Saint Regis Mohawk Tribe asked the full US Court of Appeals for the Federal Circuit on Friday to review an earlier decision that rejected use of tribal sovereign immunity in the inter partes review.
Editor's picks
Editor's picks
Americas
30 November 2017 A group of Miami police officers has filed a competition lawsuit on behalf of “potentially millions” of consumers over Allergan’s $13.75 million patent deal with the Saint Regis Mohawk Tribe.
Americas
19 January 2018 Generics company Mylan Pharmaceuticals has resisted Allergan’s attempt to withdraw itself from a series of inter partes reviews (IPRs) relating to patents covering dry-eye medication Restasis (cyclosporine ophthalmic emulsion).
Americas
21 August 2018 Allergan and the Saint Regis Mohawk Tribe asked the full US Court of Appeals for the Federal Circuit on Friday to review an earlier decision that rejected use of tribal sovereign immunity in the inter partes review.
Americas
30 November 2017 A group of Miami police officers has filed a competition lawsuit on behalf of “potentially millions” of consumers over Allergan’s $13.75 million patent deal with the Saint Regis Mohawk Tribe.
Americas
19 January 2018 Generics company Mylan Pharmaceuticals has resisted Allergan’s attempt to withdraw itself from a series of inter partes reviews (IPRs) relating to patents covering dry-eye medication Restasis (cyclosporine ophthalmic emulsion).
Americas
21 August 2018 Allergan and the Saint Regis Mohawk Tribe asked the full US Court of Appeals for the Federal Circuit on Friday to review an earlier decision that rejected use of tribal sovereign immunity in the inter partes review.